Killing in the name of: Reversing epigenetic silencing of ITPR3 to succumb cancer cells' resistance to chemotherapeutics.

Nicolas Rosa, H Llewelyn Roderick, Geert Bultynck

Journal: Cell calcium 2022;102():102526

PMID: 35007838

Full Text on Elsevier Science View on PubMed

Abstract

Address: KU Leuven, Laboratory of Molecular & Cellular Signaling, Department of Cellular & Molecular Medicine, Campus Gasthuisberg O/N-1, Herestraat 49 box 802, 3000 Leuven, Belgium.; KU Leuven, Laboratory of Experimental Cardiology, Department of Cardiovascular Sciences, Campus Gasthuisberg O/N-1, Herestraat 49 box 911, 3000 Leuven, Belgium.; KU Leuven, Laboratory of Molecular & Cellular Signaling, Department of Cellular & Molecular Medicine, Campus Gasthuisberg O/N-1, Herestraat 49 box 802, 3000 Leuven, Belgium. Electronic address: [email protected].

DOI: 10.1016/j.ceca.2022.102526

Link outs

Free resources

Medical:

https://medlineplus.gov/cancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Cell Line, Tumor, Drug Resistance, Neoplasm, Epigenesis, Genetic, Inositol 1,4,5-Trisphosphate Receptors, Neoplasms